Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 339

1.

Doctors and drug companies--scrutinizing influential relationships.

Campbell EG.

N Engl J Med. 2007 Nov 1;357(18):1796-7. No abstract available.

2.

Sunlight as disinfectant--new rules on disclosure of industry payments to physicians.

Rosenthal MB, Mello MM.

N Engl J Med. 2013 May 30;368(22):2052-4. doi: 10.1056/NEJMp1305090. No abstract available.

3.

Doctors and drug companies.

Blumenthal D.

N Engl J Med. 2004 Oct 28;351(18):1885-90. No abstract available.

PMID:
15509823
4.

Shining a light on the Sunshine Act.

Peck AA.

J Med Assoc Ga. 2013;102(2):28. No abstract available.

PMID:
24006732
5.

Cash interests taint drug advice.

Taylor R, Giles J.

Nature. 2005 Oct 20;437(7062):1070-1. No abstract available.

PMID:
16237402
6.

The Sunshine Act--effects on physicians.

Agrawal S, Brennan N, Budetti P.

N Engl J Med. 2013 May 30;368(22):2054-7. doi: 10.1056/NEJMp1303523. No abstract available.

7.

Already feeling the heat: Docs rethinking payments as Sunshine Act looms.

Lee J.

Mod Healthc. 2013 Jul 1;43(26):12-3. No abstract available.

PMID:
23878901
8.

The Sunshine Act: it's for real now.

Katayama AC.

WMJ. 2013 Apr;112(2):96-7. No abstract available.

9.

Industry relationships between physicians and professional medical associations: corrupt or essential?

Smith CD, MacFadyen B.

Surg Endosc. 2010 Feb;24(2):251-3. doi: 10.1007/s00464-009-0878-4.

PMID:
20087748
10.

Doctors and drug companies.

Lambert LA.

N Engl J Med. 2005 Feb 17;352(7):733-4; author reply 733-4. No abstract available.

11.

Clinical trial results, physicians, and insider trading.

Prentice RA.

J Leg Med. 1999 Jun;20(2):195-222. No abstract available.

PMID:
10407617
12.

Transparency urged over research payments.

Check E.

Nature. 2007 Aug 16;448(7155):738. No abstract available.

PMID:
17700667
13.

Medical students protest perks from drug companies.

Opar A.

Nat Med. 2006 Oct;12(10):1104. Epub 2006 Sep 29. No abstract available.

PMID:
17024192
14.

Doctors face compulsory system to declare gifts and hospitality from drug companies.

O'Dowd A.

BMJ. 2015 Aug 26;351:h4617. doi: 10.1136/bmj.h4617. No abstract available.

PMID:
26311722
15.

[Conflict of interest regarding clinical physicians' relationship with pharmaceutical industry and medical education].

Miyata Y.

Seishin Shinkeigaku Zasshi. 2010;112(11):1136-45. Review. Japanese.

PMID:
21226250
16.

An unhealthy practice.

[No authors listed]

Nature. 2005 Oct 20;437(7062):1065-6. No abstract available.

PMID:
16237398
17.

Physicians and clinical trials. To avoid federal scrutiny, take care when determining fair market value.

Morillo A.

Mod Healthc. 2013 Sep 23;43(38):22. No abstract available.

PMID:
24340738
18.

GMC says it can't force doctors to disclose payments from drug companies.

Torjesen I.

BMJ. 2016 Jul 7;354:i3806. doi: 10.1136/bmj.i3806. No abstract available.

PMID:
27390102
19.
20.

Two years of sunshine: has openness about payments reduced industry influence in healthcare?

Lenzer J.

BMJ. 2016 Aug 25;354:i4608. doi: 10.1136/bmj.i4608. No abstract available.

PMID:
27562781

Supplemental Content

Support Center